![](/img/cover-not-exists.png)
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study
Bergantini, L, d'Alessandro, M, Cameli, P, Carleo, A, Landi, C, Vietri, L, Lanzarone, N, Pieroni, M, Sestini, P, Bargagli, EJournal:
Internal Medicine Journal
DOI:
10.1111/imj.14768
Date:
February, 2020
File:
PDF, 1.20 MB
2020